Cargando…
Initial Experience of (18) F-FET PET-MR Image Fusion for Evaluation of Recurrent Primary Brain Tumors
Background An accurate monitoring technique is crucial in brain tumors to choose the best treatment approach after surgery and/or chemoradiation. Radiological assessment of brain tumors is widely based on the magnetic resonance imaging (MRI) modality in this regard; however, MRI criteria are unable...
Autores principales: | Dadgar, Habibollah, Vafaee, Manouchehr Seyedi, Khorasanchi, Amirreza, Moghadam, Parastoo Kordestani, Nemati, Reza, Shooli, Hossein, Jafari, Esmail, Assadi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581759/ https://www.ncbi.nlm.nih.gov/pubmed/37854091 http://dx.doi.org/10.1055/s-0043-1771282 |
Ejemplares similares
-
An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay
por: Jafari, Esmail, et al.
Publicado: (2020) -
Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies
por: Jokar, Narges, et al.
Publicado: (2019) -
Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action
por: Assadi, Majid, et al.
Publicado: (2021) -
Quality control and GMP synthesis of (68)Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer
por: Assadi, Majid, et al.
Publicado: (2019) -
Predictive and prognostic potential of pretreatment (68)Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA
por: Assadi, Majid, et al.
Publicado: (2022)